Kyntra Bio (KYNB) Total Liabilities (2016 - 2025)
Historic Total Liabilities for Kyntra Bio (KYNB) over the last 12 years, with Q3 2025 value amounting to $119.5 million.
- Kyntra Bio's Total Liabilities fell 7435.67% to $119.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $119.5 million, marking a year-over-year decrease of 7435.67%. This contributed to the annual value of $398.2 million for FY2024, which is 3202.31% down from last year.
- Latest data reveals that Kyntra Bio reported Total Liabilities of $119.5 million as of Q3 2025, which was down 7435.67% from $359.1 million recorded in Q2 2025.
- Kyntra Bio's Total Liabilities' 5-year high stood at $611.6 million during Q4 2022, with a 5-year trough of $119.5 million in Q3 2025.
- Its 5-year average for Total Liabilities is $489.7 million, with a median of $544.7 million in 2021.
- In the last 5 years, Kyntra Bio's Total Liabilities surged by 4818.93% in 2021 and then plummeted by 7435.67% in 2025.
- Over the past 5 years, Kyntra Bio's Total Liabilities (Quarter) stood at $544.7 million in 2021, then increased by 12.27% to $611.6 million in 2022, then dropped by 4.23% to $585.7 million in 2023, then tumbled by 32.02% to $398.2 million in 2024, then plummeted by 69.98% to $119.5 million in 2025.
- Its Total Liabilities stands at $119.5 million for Q3 2025, versus $359.1 million for Q2 2025 and $340.1 million for Q1 2025.